Results 1 to 10 of about 3,878,916 (126)

A Review of Fixed Drug Eruption with a Special Focus on Generalized Bullous Fixed Drug Eruption [PDF]

open access: yesMedicina, 2021
Fixed drug eruption (FDE) is a cutaneous adverse drug reaction characterized by the onset of rash at a fixed location on the body each time a specific medication is ingested. With each recurrence, the eruption can involve additional sites.
Hannah J. Anderson, Jason B. Lee
doaj   +9 more sources

Case report: Generalized bullous fixed drug eruption mimicking epidermal necrolysis [PDF]

open access: yesFrontiers in Medicine, 2023
Generalized bullous fixed drug eruption (GBFDE) is the most severe form of fixed drug eruption and can be misdiagnosed as epidermal necrolysis (EN). We report the case of a 42-year-old male patient presenting with more than 50% skin detachment without ...
Maren Paulmann   +3 more
doaj   +5 more sources

Cefotaxime induced generalized bullous fixed drug eruption - A case report [PDF]

open access: yesToxicology Reports, 2018
Fixed drug eruption (FDE) is the most common cutaneous adverse drug reaction. Cefotaxime, a broad-spectrum third-generation cephalosporin, appeared to be a safe and effective therapy in greater than 90% of infections including cellulitis, abscesses and ...
R. Manikandan   +6 more
doaj   +5 more sources

Metformin-Induced Generalized Bullous Fixed-Drug Eruption with a Positive Dechallenge-Rechallenge Test: A Case Report and Literature Review [PDF]

open access: yesCase Reports in Dermatological Medicine, 2023
Metformin is a commonly used medication in diabetic patients. It can cause different complications including cutaneous adverse reactions. Metformin-induced fixed-drug eruption (FDE) has been reported in limited cases.
Bahareh Abtahi-Naeini   +4 more
doaj   +3 more sources

Severe Generalized Bullous Fixed Drug Eruption Treated with Cyclosporine: A Case Report and Literature Review [PDF]

open access: yesCase Reports in Dermatology, 2021
Generalized bullous fixed drug eruptions (GBFDEs) are rare in the paediatric population. We present the case of a 7-year-old girl with GBFDE believed to be secondary to oral ibuprofen, who experienced rapid resolution of lesions and cessation of ...
Hailey C. Barootes   +5 more
doaj   +4 more sources

Generalized Bullous Fixed Drug Eruption Secondary to Levocetirizine: A Lesson Learned! [PDF]

open access: yesClinical Case Reports
Fixed drug eruption (FDE) is a unique type of adverse drug eruption characterized by a well‐defined erythematous to violaceous patch that recurs at the same site upon re‐exposure to causative drugs and resolves with hyperpigmentation.
Mahesh Mathur   +4 more
doaj   +3 more sources

Cross-Reactivity: a Case of Paracetamol-Induced Generalized Bullous Fixed Drug Eruption Followed by Dipyrone-Induced Fixed Drug Eruption [PDF]

open access: yesClinical, Cosmetic and Investigational Dermatology
Yuanyuan Wang,1,* Huan Xue,2,* Hejun Dai,1 Lianjuan Yang1 1Department of Medical Mycology, Center of Infectious Skin Diseases, Shanghai Skin Disease Hospital, Tongji University School of Medicine, Shanghai, People’s Republic of China; 2Department
Wang Y, Xue H, Dai H, Yang L
doaj   +4 more sources

Generalized bullous fixed drug eruption induced by chlordiazepoxide: a case report of a potentially lethal adverse effect [PDF]

open access: yesConsortium Psychiatricum
BACKGROUND: Fixed drug eruption is a type of adverse drug reaction affecting the skin, marked by recurrent rashes that appear at the same site each time a particular drug is taken.
Rishabh Singh   +3 more
doaj   +4 more sources

Generalized bullous drug eruption triggered by ceftriaxone: a case report and literature overview [PDF]

open access: yesDermatology Reports
Ceftriaxone is a widely used third-generation cephalosporin antibiotic known for its efficacy and safety. However, hypersensitivity reactions, including rare cases of generalized bullous fixed drug eruption (GBFDE), have been reported.
Khuzama Alfalah   +2 more
doaj   +2 more sources

Cyclosporine in generalized bullous-fixed drug eruption [PDF]

open access: yesIndian Journal of Dermatology, 2018
Ranjana Beniwal   +5 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy